Showing results (41-50 of 301) with videos related to

Sort By:
Pageof 31
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1990
Dichloroacetate attenuates myocardial acidosis and metabolic changes induced by partial occlusion of the coronary artery in dogsK Sakai, K Ichihara, Y Nasa, et al.
Western Pacific Surveillance and Response Journal : WPSAR|November 14, 2019
An enterohaemorrhagic Escherichia coli outbreak spread through the environment at an institute for people with intellectual disabilities in Japan in 2005Masaki Ota, Taro Kamigaki, Satoshi Mimura, et al.
Japanese Journal of Cancer Research : Gann|October 26, 2001
High expression of thymidylate synthase leads to resistance to 5-fluorouracil in biliary tract carcinoma in vitroK Habara, T Ajiki, T Kamigaki, et al.
Hepato-Gastroenterology|May 31, 2001
Evaluation of gastroenteric bypass for unresectable pancreatic cancerY Fujino, Y Suzuki, T Kamigaki, et al.
The Journal of Veterinary Medical Science|July 10, 2020
Sexual dimorphism in external morphology of the American bullfrog Rana (Aquarana) catesbeiana and the possibility of sex determination based on tympanic membrane/eye size ratioMasakazu Asahara, Yumi Obayashi, Ayano Suzuki, et al.
Influenza and Other Respiratory Viruses|July 22, 2014
Epidemiology and impact of influenza in Mongolia, 2007-2012Alexanderyn Burmaa, Taro Kamigaki, Badarchyn Darmaa, et al.
Plant & Cell Physiology|May 5, 2007
Functional classification of Arabidopsis peroxisome biogenesis factors proposed from analyses of knockdown mutantsKazumasa Nito, Akane Kamigaki, Maki Kondo, et al.
Preventing Chronic Disease|January 7, 2005
Osteoporosis and health-related quality-of-life outcomes in the Alameda County Study populationKrista Kotz, Stephane Deleger, Richard Cohen, et al.
Plant & Cell Physiology|November 7, 2009
Suppression of peroxisome biogenesis factor 10 reduces cuticular wax accumulation by disrupting the ER network in Arabidopsis thalianaAkane Kamigaki, Maki Kondo, Shoji Mano, et al.
In Vivo (Athens, Greece)|February 25, 2018
The Difference in Prognostic Outcomes Between De Novo Stage IV and Recurrent Metastatic Patients with Hormone Receptor-positive, HER2-negative Breast CancerJun Yamamura, Shunji Kamigaki, Junya Fujita, et al.
Pageof 31